Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12407162 | PMC |
| http://dx.doi.org/10.1097/CM9.0000000000003748 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cardiovascular, kidney, and metabolic health: an actionable vision for heart failure prevention.
Lancet
August 2025
Cardiovascular Division, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. Electronic address:
The substantial and growing prevalence of heart failure, which remains the leading cause of preventable hospitalisation worldwide, has brought heart failure prevention into sharp focus. Although this condition has historically been characterised by impaired cardiac function, mounting evidence has underscored its complex and multisystem pathobiology. Epidemiological studies have indicated that other forms of cardiovascular disease, along with kidney and metabolic dysfunction, frequently and increasingly contribute to heart failure onset.
View Article and Find Full Text PDFImplementation Barriers to Evidence-Based Cardiovascular-Kidney-Metabolic Syndrome Management.
Heart Lung Circ
August 2025
Department of Nephrology, Prince of Wales Hospital, Sydney, NSW, Australia; Renal and Metabolic Division, The George Institute for Global Health, UNSW Sydney, Sydney, NSW, Australia. Electronic address:
Cardiovascular-kidney-metabolic (CKM) syndrome is a newly defined health syndrome, encompassing the overlapping pathophysiology and risk factors of cardiovascular and kidney disease, obesity, and type 2 diabetes. It is the leading cause of morbidity and mortality worldwide, with an annual health cost of approximately AUD $24 billion in Australia alone. A disproportionate burden is observed among those with adverse social determinants of health.
View Article and Find Full Text PDFThe JSH Morning Hypertension Eradication Program Project.
Hypertens Res
August 2025
Department of Cardiovascular Medicine, Saga University, Saga, Japan.
Hypertension is the greatest risk factor for cardiovascular diseases and significantly contributes to cardiovascular mortality. In Japan, the hypertensive population is estimated at 43 million, with only 27% achieving well-controlled blood pressure (BP). The onset of major cardiovascular events, including stroke, myocardial infarction, heart failure, and aortic dissection, frequently occurs during the early morning hours.
View Article and Find Full Text PDFKidney Disease: Improving Global Outcomes Summit Recommendations on Implementation of Diabetes Management in CKD: From Primary to Data-Driven Collaborative Care.
Kidney Int Rep
August 2025
Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong Special Administrative Region, China.
Type 2 diabetes and chronic kidney disease (CKD) are preventable and treatable. Their silent and progressive clinical course calls for structured assessment with timely feedback to patients and care providers for activating decision-making. Apart from CKD, patients with diabetes can have complications affecting multiple organs, notably the cardiovascular system, eyes, and feet.
View Article and Find Full Text PDFOptimizing Care for Cardiovascular-Kidney-Metabolic Syndrome: Leveraging Implementation Science in the Path Toward Pharmacoequity.
Curr Cardiol Rep
August 2025
Institute for Health Equity Research, Department of Population Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Purpose Of Review: Overview the current landscape of pharmacoequity in cardiovascular-kidney-metabolic (CKM) syndrome.
Recent Findings: CKM syndrome is a key driver of the significant morbidity and mortality associated with cardiovascular disease, and poses a significant threat to public health. Despite a growing armamentarium of evidence-based therapies for the prevention and management of CKM syndrome, access to these treatments remains unequal.